Michael Crager

  • Genomic Health, Inc
  • Business / Corporate Professional, Statistics
  • United States

My Publications

Separate Class True Discovery Rate Degree of Association Sets for Biomarker Identification

  • Journal of Biopharmaceutical Statistics
  • August 2014

Risk Assessment Using Patient-Specific Meta-Analysis

  • Journal of Applied Statistics
  • June 2014

Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fi...

  • PLoS ONE
  • July 2012

Identification Power in FDR Analyses

  • Genetic Epidemiology
  • July 2012

Standardized Hazard Ratio for Multivariate Cox Regression

  • Journal of Applied Statistics
  • February 2012

PD03-09: Breast Cancer Recurrence Risk Probed by Whole Transcriptome Next Generation Se...

  • Cancer Research
  • December 2011

Abstract S4-9: Comparing the Prediction of Chemotherapy Benefit in Patients with Node-N...

  • Cancer Research
  • December 2010

TDRDA Discovery Analyses

  • Statistics in Medicine
  • January 2009

Safety and Efficacy of Extended-Release Ranolazine in Patients Aged 70 Years or Older W...

  • The American Journal of Geriatric Cardiology
  • July 2007

Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable An...

  • Journal of the American College of Cardiology
  • March 2007

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus P...

  • The Journal of Infectious Diseases
  • September 1993

Developing clinical trial quality management principles

  • Controlled Clinical Trials
  • October 1992

Running Average Analysis of Clinical Trial Ambulatory Blood Pressure Data

  • Biometrics
  • March 1991

Analysis of Covariance Using Pretreatment Baselines

  • Biometrics
  • December 1987

Met-enkephalin, age and anatomy: A microiontophoretic study in the hippocampus

  • Life Sciences
  • January 1987

Acetylcholine, aging and anatomy: differential effects in the hippocampus

  • Brain Research
  • January 1986